https://www.thebodypro.com/article/fda-approves-sovaldi-sofosbuvir-for-chronic-hepati
Adverse Events, Comorbidities, and HIVNews

FDA Approves Sovaldi (Sofosbuvir) for Chronic Hepatitis C

Drug Is Third With Breakthrough Therapy Designation to Receive FDA Approval

    U.S. Food and Drug Administration

    U.S. Food and Drug Administration